Regeneron Pharmaceuticals

REGN

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kin …

Insider trades and stock quote 2024-2026

All insider trades at Regeneron Pharmaceuticals

Subscribe RSS
Date Type Insider Position Ø-Price Volume
11/4/2026 Sell Pitofsky, Jason SVP Controller $943.5 $3,827,160
11/3/2026 Sell Zoghbi, Huda Y. Director $970.7 $7,219,274
11/2/2026 Sell Poon, Christine A. Director $969.0 $7,587,957
11/2/2026 Sell Sing, George L. Director $964.7 $20,376,359
11/2/2026 Sell Larosa, Joseph J. EVP General Counsel and Secret $965.8 $4,311,890
10/30/2026 Sell Brown, Michael S. Director $875.0 $1,687,875
10/30/2026 Sell Mccourt, Marion EVP Commercial $869.4 $984,195
10/30/2026 Sell Guarini, Kathryn Director $900.0 $360,000
10/14/2026 Sell Murphy, Andrew J. Co-Chief Scientific Officer $768.4 $3,204,377
9/3/2026 Sell Mccourt, Marion EVP Commercial $857.4 $969,708
9/2/2026 Sell Mccourt, Marion EVP Commercial $850.0 $1,032,750
9/2/2026 Sell Guarini, Kathryn Director $850.0 $340,000
8/10/2026 Sell Zoghbi, Huda Y. Director $800.0 $640,000
8/10/2026 Sell Guarini, Kathryn Director $800.0 $320,000
7/2/2026 Sell Ryan, Arthur F. Director $650.2 $130,030
5/1/2026 Sell Ryan, Arthur F. Director $707.5 $70,524
4/1/2026 Sell Ryan, Arthur F. Director $775.5 $77,727
3/2/2026 Sell Ryan, Arthur F. Director $783.5 $78,548
2/19/2026 Sell Zoghbi, Huda Y. Director $781.4 $1,279,812
2/9/2026 Sell Ryan, Arthur F. Director $781.5 $77,854
2/9/2026 Sell Pitofsky, Jason SVP Controller $780.5 $1,585,058
1/7/2026 Sell Bassler, Bonnie L. Director $800.0 $1,200,000
11/20/2025 Sell Bassler, Bonnie L. Director $750.0 $570,000
11/7/2025 Sell Pitofsky, Jason VP Controller $651.4 $280,766
10/29/2025 Sell Poon, Christine A. Director $654.9 $4,252,746
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)